![Nathan Mata](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathan Mata
Hoofd Techniek/Wetenschap/O&O bij
BELITE BIO, INC
Vermogen: 3 M $ op 30-06-2026
Profiel
Nathan L.
Mata is the founder of ReVision Therapeutics, Inc., founded in 2010, where the title held was Chief Scientific Officer from 2010 to 2012.
Dr. Mata was the founder of Sytera, Inc., founded in 2004, where the title held was Director from 2004 to 2006.
Dr. Mata currently holds the position of Chief Scientific Officer at Belite Bio LLC since 2021.
Dr. Mata currently holds the position of Chief Scientific Officer at Belite Bio, Inc. since 2021.
Former jobs include COO, Director-Research & Development Section at Trethera Corp.
from 2015 to 2017; Chief Scientific Officer, Senior VP-R&D Sector at Sirion Therapeutics, Inc. from 2008 to 2010; and Principal at Jules Stein Eye Institute.
Education includes undergraduate, graduate, and doctorate degrees from The University of Texas at Austin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BELITE BIO, INC. 0,07% | 07-05-2026 | 16.666 ( 0,07% ) | 3 M $ | 30-06-2026 |
Actieve functies van Nathan Mata
| Bedrijven | Functie | Begin |
|---|---|---|
| BELITE BIO, INC | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
Belite Bio LLC
 Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | Hoofd Techniek/Wetenschap/O&O | 01-08-2021 |
Eerdere bekende functies van Nathan Mata
| Bedrijven | Functie | Einde |
|---|---|---|
Trethera Corp.
 Trethera Corp. Pharmaceuticals: MajorHealth Technology Develops molecule therapies for autoimmune and cancer diseases | Operationeel Directeur | 01-01-2017 |
ReVision Therapeutics, Inc.
 ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade Develops drugs for the treatment of age-related macular degeneration diseases | Oprichter | 01-01-2012 |
Sirion Therapeutics, Inc.
 Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 |
Sytera, Inc.
 Sytera, Inc. BiotechnologyHealth Technology Provides biopharmaceutical services and products | Oprichter | 01-01-2006 |
Jules Stein Eye Institute
 Jules Stein Eye Institute Other Consumer ServicesConsumer Services Operates as eye institute | Corporate Officer/Principal | - |
Opleiding van Nathan Mata
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
ReVision Therapeutics, Inc.
ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade Develops drugs for the treatment of age-related macular degeneration diseases | Retail Trade |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sirion Therapeutics, Inc.
Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services | Health Technology |
Sytera, Inc.
Sytera, Inc. BiotechnologyHealth Technology Provides biopharmaceutical services and products | Health Technology |
Jules Stein Eye Institute
Jules Stein Eye Institute Other Consumer ServicesConsumer Services Operates as eye institute | Consumer Services |
Trethera Corp.
Trethera Corp. Pharmaceuticals: MajorHealth Technology Develops molecule therapies for autoimmune and cancer diseases | Health Technology |
Belite Bio LLC
Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | Health Technology |
Belite Bio, Inc.
 Belite Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical drug development company | Health Technology |
